A randomized controlled trial of continuous positive airway pressure on glucose tolerance in obese patients with obstructive sleep apnea
N Salord, AM Fortuna, C Monasterio, M Gasa, A Pérez… - Sleep, 2016 - academic.oup.com
Study Objectives: Obstructive sleep apnea (OSA) is associated with an increased prevalence
of metabolic syndrome (MetS), even in patients with morbid obesity. Our goal was to …
of metabolic syndrome (MetS), even in patients with morbid obesity. Our goal was to …
[HTML][HTML] Evolving mortality and clinical outcomes of hospitalized subjects during successive COVID-19 waves in Catalonia, Spain
Background The changes in shield strategies, treatments, emergence variants, and healthcare
pathways might shift the profile and outcome of patients hospitalized with COVID-19 in …
pathways might shift the profile and outcome of patients hospitalized with COVID-19 in …
Impact of OSA on biological markers in morbid obesity and metabolic syndrome
N Salord, M Gasa, M Mayos… - Journal of Clinical …, 2014 - jcsm.aasm.org
Background and Objective: There is compelling evidence that obstructive sleep apnoea (OSA)
can affect metabolic syndrome (MetS) and cardiovascular risk, but the intermediate …
can affect metabolic syndrome (MetS) and cardiovascular risk, but the intermediate …
Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure
M Gasa, R Tamisier, SH Launois… - Journal of sleep …, 2013 - Wiley Online Library
Hypoxic brain damage might explain persistent sleepiness in some continuous positive
airway pressure‐compliant obstructive sleep apnea called residual excessive sleepiness. …
airway pressure‐compliant obstructive sleep apnea called residual excessive sleepiness. …
Obstructive sleep apnoea and metabolic impairment in severe obesity
M Gasa, N Salord, AM Fortuna, M Mayos… - European …, 2011 - Eur Respiratory Soc
Obstructive sleep apnoea (OSA) seems to worsen metabolism. This effect has not been
evaluated in morbid obesity (MO). We hypothesised that the metabolic profile is more impaired in …
evaluated in morbid obesity (MO). We hypothesised that the metabolic profile is more impaired in …
[HTML][HTML] COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study
…, T Pickworth, M Molina-Molina, M Gasa… - ERJ open …, 2023 - Eur Respiratory Soc
Granulocyte–macrophage colony-stimulating factor (GM-CSF) signalling is essential in both
alveolar macrophage (AM) differentiation and activation of lung immune cells [1]. …
alveolar macrophage (AM) differentiation and activation of lung immune cells [1]. …
[HTML][HTML] Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness
…, N Padulles, M Gonzalez, X Solanich, M Gasa… - International Journal of …, 2020 - Elsevier
Objectives To assess the characteristics and risk factors for mortality in patients with severe
coronavirus disease-2019 (COVID-19) treated with tocilizumab (TCZ), alone or in …
coronavirus disease-2019 (COVID-19) treated with tocilizumab (TCZ), alone or in …
Anthropometrical phenotypes are important when explaining obstructive sleep apnea in female bariatric cohorts
M Gasa, C López‐Padrós, C Monasterio… - Journal of sleep …, 2019 - Wiley Online Library
Central obesity is the main risk factor for obstructive sleep apnea ( OSA ). Whether there
exists a central‐obesity anthropometric that better explains apnea–hypopnea index ( AHI ) …
exists a central‐obesity anthropometric that better explains apnea–hypopnea index ( AHI ) …
Optimizing screening of severe obstructive sleep apnea in patients undergoing bariatric surgery
M Gasa, N Salord, AM Fortuna, M Mayos… - Surgery for obesity and …, 2013 - Elsevier
… Author links open overlay panel Mercè Gasa MD a b c , Neus Salord MD a b d , Ana M.
Fortuna MD d e , Mercedes Mayos MD d e f , Cristina Embid MD c d g , Núria Vilarrasa MD d h , …
Fortuna MD d e , Mercedes Mayos MD d e f , Cristina Embid MD c d g , Núria Vilarrasa MD d h , …
Effectiveness of an intensive weight-loss program for severe OSA in patients undergoing CPAP treatment: a randomized controlled trial
…, N Salord, C Alves, N Vilarrasa, M Gasa… - Journal of Clinical …, 2020 - jcsm.aasm.org
Study Objectives: To determine whether an intensive weight-loss program (IWLP) is effective
for reducing weight, the severity of obstructive sleep apnea (OSA), and metabolic variables …
for reducing weight, the severity of obstructive sleep apnea (OSA), and metabolic variables …